NCT01928628View on ClinicalTrials.gov

Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

449

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

April 30, 2013

Conditions
Hypertension
Interventions
DRUG

Lercanidipine 10mg

DRUG

Lercanidipine10mg /Valsartan 80mg

DRUG

Lercanidipine 10mg /Valsartan 160mg

DRUG

Lercanidipin 10mg Placebo

DRUG

Lercanidipine10mg /Valsartan 80mg Placebo

DRUG

Lercanidipine 10mg /Valsartan 160mg Placebo

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

LG Life Sciences
All Listed Sponsors
lead

LG Life Sciences

INDUSTRY

NCT01928628 - Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients | Biotech Hunter | Biotech Hunter